This is an old revision of this page, as edited by Beetstra (talk | contribs) at 15:59, 16 December 2010 (Script assisted update of identifiers from ChemSpider, CommonChemistry and FDA for the Chem/Drugbox validation project - Updated: InChI1->InChI StdInChI StdInChIKey.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 15:59, 16 December 2010 by Beetstra (talk | contribs) (Script assisted update of identifiers from ChemSpider, CommonChemistry and FDA for the Chem/Drugbox validation project - Updated: InChI1->InChI StdInChI StdInChIKey.)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Trospium chloride" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message) |
Clinical data | |
---|---|
ATC code | |
Pharmacokinetic data | |
Protein binding | 50-85% |
Elimination half-life | 20 hours |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.030.784 |
Chemical and physical data | |
Formula | C25H30NO3 |
Molar mass | 392.511 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Trospium is a urinary antispasmodic. It is sold under the brand name Sanctura in the US, Trosec in Canada, Regurin in the United Kingdom and Spasmex in Croatia and Israel.
It is available in Egypt under the brand name Trospikan by Hikma pharma.
Urologicals, including antispasmodics (G04B) | |
---|---|
Acidifiers | |
Urinary antispasmodics (primarily antimuscarinics) | |
Other urologicals |
|
This medical article is a stub. You can help Misplaced Pages by expanding it. |